These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19732965)

  • 1. Author's response to letter to the editor by Kauffman et al. published in JNI 212/1-2, June 2009.
    Vécsei L; Losonczi E; Bencsik K; Rajda C
    J Neuroimmunol; 2009 Dec; 217(1-2):102. PubMed ID: 19732965
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumour necrosis factor alpha gene (TNF-alpha) -376 polymorphism in Hungarian patients with primary progressive multiple sclerosis.
    Losonczi E; Bencsik K; Nagy ZF; Honti V; Szalczer E; Rajda C; Illés Z; Mátyás K; Rózsa C; Csépány T; Füvesi J; Vécsei L
    J Neuroimmunol; 2009 Mar; 208(1-2):115-8. PubMed ID: 19201038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment to Tumour necrosis factor alpha gene -376 polymorphism in Hungarian patients with primary progressive multiple sclerosis.
    Kauffman MA; Villa AM
    J Neuroimmunol; 2009 Jul; 212(1-2):151. PubMed ID: 19446891
    [No Abstract]   [Full Text] [Related]  

  • 4. Author's response to Letter to the Editor by N. Messaoudani, R. Djidjik and M. Ghaffor published in JNI 266 (2014) entitled "Comments on CSF κFLC assay evaluation in assessing intrathecal synthesis".
    Pieri M; Pignalosa S; Zenobi R; Dessi M
    J Neuroimmunol; 2017 May; 306():19. PubMed ID: 28385182
    [No Abstract]   [Full Text] [Related]  

  • 5. Critically associating.
    Stalets E; Wong HR
    Crit Care Med; 2009 Apr; 37(4):1492-3. PubMed ID: 19318832
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumor necrosis factor polymorphisms and alcoholic liver disease: a HuGE review and meta-analysis.
    Marcos M; Gómez-Munuera M; Pastor I; González-Sarmiento R; Laso FJ
    Am J Epidemiol; 2009 Oct; 170(8):948-56. PubMed ID: 19755636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regarding the article by Timmers et al.
    Frantz S; Bauersachs J
    Circ Res; 2009 Jun; 104(11):e60; author reply e61. PubMed ID: 19498206
    [No Abstract]   [Full Text] [Related]  

  • 8. Ankylosing spondylitis susceptibility and severity--contribution of TNF gene promoter polymorphisms at positions -238 and -308.
    Sousa E; Caetano-Lopes J; Pinto P; Pimentel F; Teles J; Canhão H; Rodrigues A; Resende C; Mourão AF; Ribeiro C; Pinto TL; Rosa CM; da Silva JA; Branco J; Ventura F; Queiroz MV; Fonseca JE
    Ann N Y Acad Sci; 2009 Sep; 1173():581-8. PubMed ID: 19758203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligoclonal bands in hereditary diffuse leukencephalopathy with spheroids.
    Levin J; Danek A
    Eur J Neurol; 2015 Apr; 22(4):e48. PubMed ID: 25753564
    [No Abstract]   [Full Text] [Related]  

  • 10. Progressive multiple sclerosis does not associate with rs996343 and rs2046748.
    Bernales CQ; Ross JP; Lee JD; Zhao Y; Sadovnick AD; Traboulsee AL; Vilariño-Güell C
    Mult Scler; 2014 May; 20(6):766-7. PubMed ID: 24368757
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases.
    Brettschneider J; Jaskowski TD; Tumani H; Abdul S; Husebye D; Seraj H; Hill HR; Fire E; Spector L; Yarden J; Dotan N; Rose JW
    J Neuroimmunol; 2009 Dec; 217(1-2):95-101. PubMed ID: 19879655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combinations of TNFalpha-308 and IL-6 -174 or IL-10 -1082 genes polymorphisms suggest an association with susceptibility to sporadic late-onset Alzheimer's disease.
    Vural P; Değirmencioğlu S; Parildar-Karpuzoğlu H; Doğru-Abbasoğlu S; Hanagasi HA; Karadağ B; Gürvit H; Emre M; Uysal M
    Acta Neurol Scand; 2009 Dec; 120(6):396-401. PubMed ID: 19744138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to letter to the editor by eisner et al.
    Teshima Y; Takahashi N; Saikawa T; Hara M; Yasunaga S; Hidaka S; Sakata T
    J Mol Cell Cardiol; 2000 Jul; 32(7):1379. PubMed ID: 10860778
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter to the editor regarding Reig et al., Thermocoagulation of the ganglion impar of Walther: description of a modified approach. Preliminary results in chronic, nononcological pain. Pain Practice 2005;5(2):103-110.
    Russo MA
    Pain Pract; 2005 Dec; 5(4):367; author reply 367-8. PubMed ID: 17177774
    [No Abstract]   [Full Text] [Related]  

  • 15. Differences in age of diagnosis in familial multiple sclerosis.
    Pytel V; Matias-Guiu JA; Torre-Fuentes L; Montero-Escribano P; Matias-Guiu J
    Mult Scler Relat Disord; 2019 Sep; 34():91. PubMed ID: 31247474
    [No Abstract]   [Full Text] [Related]  

  • 16. A Letter to the Editor on the Article by Farnam et al.-Author's Response.
    Farnaz F; Janghorbani M; Merghati-Khoei E
    Sex Med; 2015 Sep; 3(3):219. PubMed ID: 26468385
    [No Abstract]   [Full Text] [Related]  

  • 17. Author's re`sponse to letter to the editor from Hayırlıoğlu M et al.
    Cagdas M
    J Electrocardiol; 2018; 51(2):354-355. PubMed ID: 29454650
    [No Abstract]   [Full Text] [Related]  

  • 18. Author's reply: Letter to the editor in response to Akita et al. (2020).
    Akita K; Inohara T; Kohsaka S; Amano T; Ikari Y; Maekawa Y
    Eur Heart J Cardiovasc Pharmacother; 2021 May; 7(3):e60. PubMed ID: 32991674
    [No Abstract]   [Full Text] [Related]  

  • 19. The natural history of primary progressive multiple sclerosis.
    Koch M; Kingwell E; Rieckmann P; Tremlett H
    Neurology; 2009 Dec; 73(23):1996-2002. PubMed ID: 19996074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleak prospects for primary progressive multiple sclerosis therapy: downs and downs, but a glimmer of hope.
    Hartung HP; Aktas O
    Ann Neurol; 2009 Oct; 66(4):429-32. PubMed ID: 19847907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.